Collectively, our findings demonstrate that the ALG3-FOXD1 axis enhances mitophagy by transcriptionally activating BNIP3 expression, thereby promoting NPC progression and modulating the response of NPC cells to gemcitabine. The gene discussed is ALG3; the disease is nasopharyngeal carcinoma.